Gensler, L. S.
Chakravarty, S. D.
Cameron, Chris
Peterson, S.
Spin, P.
Kafka, S.
Nair, S.
Deodhar, A.
Article History
Received: 22 November 2019
Revised: 28 February 2020
Accepted: 20 March 2020
First Online: 4 May 2020
Compliance with ethical standards
:
: Cornerstone received financial support from Janssen Scientific Affairs, LLC, for the conduct of this study. S.D. Chakravarty, S. Peterson, and S. Kafka are employees and shareholders of Johnson and Johnson. S. Nair is an employee of Johnson and Johnson. C. Cameron is an employee and shareholder of EVERSANA™. P. Spin is an employee of EVERSANA™. EVERSANA™ consults for various pharmaceutical, medical device, and biotech companies.AD has received research grants and/or has served on the advisory boards of AbbVie, Amgen, Boeheringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Galapagos, Galxo Smith & Klien, Janssen, Novartis, Pfizer and UCB.LSG has received research grants and/or has served on the advisory boards of AbbVie, Amgen, Eli Lilly, Galapagos, Janssen, Novartis, Pfizer, and UCB.